Related by context. All words. (Click for frequent words.) 71 Temsirolimus 70 PNP inhibitor 70 MAGE A3 ASCI 70 selective kinase inhibitor 70 demonstrated antitumor activity 69 generation purine nucleoside 69 radiation sensitizer 69 receptor tyrosine kinase inhibitor 69 orally administered inhibitor 69 BCR ABL inhibitors 68 oral ghrelin agonist 68 CTAP# Capsules 68 Quinamed 68 LHRH receptor positive 68 essential thrombocythemia ET 68 evaluating tivozanib 68 novel VDA molecule 68 RhuDex R 68 refractory chronic lymphocytic 68 cyclin dependent kinase inhibitor 68 targeted antifolate 68 thalidomide Thalomid 68 AKT inhibitor 68 humanized monoclonal 68 liposomal formulation 68 antibody MAb 67 immunoconjugate 67 somatostatin analogue 67 relapsed MM 67 PI3K/Akt pathway inhibitor 67 selective modulator 67 PDE4 inhibitor 67 multi kinase inhibitor 67 RhuDex ® 67 histone deacetylase inhibitor 67 dasatinib Sprycel ® 67 anticancer compound 67 chimeric monoclonal antibody 67 Epigenomics proprietary 67 candidate deforolimus 67 accumulate preferentially 67 forodesine 66 Safinamide 66 ospemifene 66 Fc fusion protein 66 IMiDs ® 66 bladder ovarian 66 metaglidasen 66 GVAX ® 66 immune modulating 66 GW# [003] 66 Imatinib mesylate 66 denileukin diftitox 66 YONDELIS 66 mertansine 66 Silodosin 66 brivanib 66 vinca alkaloid 66 CYT# potent vascular disrupting 66 kidney urologic 66 goserelin 66 Panzem R NCD 66 Intravenous CP 66 Gleevec resistant 66 taxane derivative 66 Hsp# Inhibitor 66 acyclovir Lauriad R 66 SinuNase ™ 66 Orally administered 66 leukemia AML 66 YONDELIS R 66 imatinib Gleevec ® 66 proteasome inhibitor 66 erlotinib Tarceva ® 66 MKC# MT 66 agonistic human 66 castrate resistant prostate cancer 66 potently inhibit 66 Onconase 66 gefitinib Iressa 66 immunotherapeutic approaches 66 vinorelbine tartrate 66 monoclonal antibody conjugated 66 Hodgkin lymphoma HL 66 Vidaza azacitidine 65 Solazed TM 65 NPC 1C 65 advanced metastatic renal 65 Fludara ® 65 acadesine 65 humanised antibody 65 mTOR mammalian target 65 Immunotherapeutic 65 gastrointestinal stromal tumors GISTs 65 ZACTIMA 65 multikinase inhibitor 65 Monoclonal antibody 65 LungAlert TM 65 compound perifosine 65 NB S# strontium malonate 65 Panzem NCD 65 Darinaparsin 65 hyaluronidase enzyme 65 SuperAntibody 65 non nucleoside inhibitor 65 antisense inhibitors 65 investigational immunotherapy 65 dasatinib Sprycel 65 metastatic hormone refractory 65 Peginterferon alfa 2b 65 relapsed leukemia 65 resistant hormone refractory 65 Squalamine 65 pan HDAC inhibitor 65 antimitotic 65 cortisol synthesis 65 anticancer therapeutics 65 beta 1a 65 Pertuzumab 65 IMiDs R 65 recurrent NSCLC 65 paclitaxel Taxol 65 targeted radiotherapeutic 65 potent antiproliferative 65 Phase #b/#a clinical 65 VitiGam 65 selective orally bioavailable 65 long acting muscarinic 65 mitogen activated ERK kinase 65 Evoltra ® 65 SPRYCEL ® 65 SYN# 65 hypoxia activated prodrug 65 FOLFOX6 chemotherapy regimen 65 LAB CGRP 65 angiogenesis inhibitor 65 nucleoside analogue 65 paclitaxel Taxol ® 65 Romidepsin 64 gemcitabine Gemzar ® 64 Tarceva TM 64 therapeutic monoclonal antibody 64 etanercept Enbrel 64 oral Janus kinase 64 tubulin inhibitor 64 PSMA ADC 64 OncoVex 64 highly selective inhibitor 64 deCODE ProstateCancer TM 64 Letairis ambrisentan 64 HuMax 64 Nilotinib 64 Omacetaxine 64 deCODE AF TM 64 mGluR2 NAM 64 diagnostic biomarker 64 Amrubicin 64 MGd 64 immunotherapeutic vaccine 64 immunomodulator 64 papillary renal cell carcinoma 64 evaluating satraplatin 64 Daclizumab 64 ENMD # 64 sorafenib tablets 64 Degarelix 64 oral salmon calcitonin 64 Taxotere docetaxel 64 Alferon N 64 metastatic colorectal 64 small molecule Hedgehog 64 MOVIPREP R 64 metastatic bladder 64 oncolytic virus therapies 64 novel oral anticoagulant 64 PGL# 64 platinum chemotherapeutic 64 M2 subunit 64 Zolpimist ™ 64 ® bortezomib 64 nucleoside analog 64 Phase IIb clinical trials 64 Hycamtin ® 64 TNF Tumor Necrosis Factor 64 advanced hepatocellular carcinoma 64 cutaneous T 64 PEGylated interferon 64 5 HT2A serotonin 64 Akt inhibitor 64 Onalta ™ 64 novel therapeutic antibodies 64 tumor vascular disrupting 64 Archexin 64 telomerase therapeutic 64 small molecule thrombopoietin 64 sorafenib Nexavar 64 antiproliferative effects 64 intranasal formulation 64 neratinib 64 Laquinimod 64 BCR ABL inhibitor 64 OMP #M# 64 oral immunomodulatory 64 nucleotide analog 64 multicenter Phase II 64 PEGylated Fab fragment 64 metastatic gastric 64 Ceflatonin 64 Albuferon TM 64 erlotinib Tarceva 64 TBC# 64 Aurora kinase inhibitor 64 Myolimus 64 alvespimycin 64 Elvitegravir 64 PKC# 64 Panzem R 64 microtubule inhibitor 64 LHRH agonists 64 Xeloda ® 64 endothelin receptor 64 miRNA biomarkers 64 hepatitis C HCV 64 highly selective endothelin 64 tramiprosate Alzhemed TM 64 Nexavar ® 64 candidates Azedra TM 64 vidofludimus 64 drug GAP #B# 63 histone deacetylase HDAC inhibitor 63 metastatic malignant 63 ErbB2 positive 63 ALK inhibitors 63 Angiotensin Converting Enzyme 63 2A receptor agonist 63 protein tyrosine phosphatase 1B 63 selective immunoproteasome inhibitor 63 Epratuzumab 63 irreversible inhibitor 63 Luteinizing Hormone Releasing Hormone 63 lymphoid malignancies 63 Pathway Inhibitor 63 2 inhibitor CYT# 63 cholesteryl ester transfer 63 adalimumab Humira 63 Platinol ® cisplatin 63 VEGFR2 inhibitor 63 ELACYT 63 R sorafenib tablets 63 immunotoxin 63 Aflibercept 63 Cimzia TM 63 FOLOTYN ® 63 thetreatment 63 reslizumab 63 Xanafide 63 cisplatin gemcitabine 63 Pruvel TM 63 Vidaza R 63 investigational integrase inhibitor 63 Cx# [002] 63 proprietary polysaccharide 63 acid phosphatase PAP 63 Bucindolol 63 docetaxel Taxotere ® 63 huC# DM4 63 riboflavin vitamin B2 63 immunotherapeutic agent 63 Abiraterone acetate 63 pancreatic enzyme replacement 63 JAK2 inhibitor 63 XL# XL# 63 Gleevec Glivec 63 ThermoDox R 63 Teysuno 63 initiated Phase Ib 63 PSN# [001] 63 LymphoStat B belimumab 63 Transdermal Patch 63 P#X# antagonist 63 cell lymphoma CTCL 63 humanized monoclonal antibodies 63 Levoleucovorin 63 hypereosinophilic syndrome 63 alkylating agent 63 radiation chemoradiation 63 tumor activated prodrug 63 NeuVax 63 alefacept 63 rituximab Rituxan 63 oral prodrug 63 non resectable 63 rxRNA 63 JAK inhibitors 63 HER2 ErbB2 63 pediatric acute lymphoblastic 63 Transdrug R 63 androgen receptor AR 63 non porcine pancreatic 63 HQK 63 SAR# [004] 63 pertuzumab 63 GV# [001] 63 Angiolix 63 CEQ# 63 developing Zerenex ferric 63 aurora kinase 63 vascular disrupting agent 63 Clusterin 63 cyclophosphamide methotrexate 63 ribonucleotide reductase clinically validated 63 Spiegelmer ® 63 potent inducer 63 Allovectin 7 63 anti PlGF 63 INS# [001] 63 triggers apoptosis programmed 63 Blinatumomab 63 RNA antagonists 63 peptidic compound 63 PHX# 63 LymphoStat B TM 63 Alzhemed TM 63 Curaxin CBLC# 63 Factor Receptor 63 MCSP respectively 63 anti CD3 monoclonal 63 immune modulator 63 cetuximab Erbitux R 63 imatinib Gleevec 63 multitargeted 63 Septin9 63 Pralatrexate 63 receptor inhibitor 63 Lubiprostone 63 metastatic androgen independent 63 Ph + acute lymphoblastic 63 Selective Electrochemical Tumor Ablation 63 Xeloda capecitabine 63 MTP inhibitor 63 Tovaxin TM 63 Amgen Neulasta R 63 IgG1 monoclonal antibody 63 Velcade bortezomib 63 Vidaza ® 63 inhaled AAT 63 IMA# 63 cathepsin K inhibitor 63 Marqibo TM 63 indinavir Crixivan 63 PEGylated anti 63 novel histone deacetylase 63 Canvaxin TM 63 isoform selective 63 2 methoxyestradiol 63 Bezielle 63 Aplidin 63 RhuDex TM 63 telomerase inhibitor 63 SERMs 63 FUSILEV enhances 63 advanced metastatic prostate 63 anti amnesic 63 lenalidomide Revlimid 63 selective estrogen receptor modulator 63 Tarvacin TM 63 CD3 monoclonal antibody 63 metastatic castrate resistant 63 ixabepilone 63 Apoptone 63 sodium glucose cotransporter 63 Dapagliflozin 62 ADP receptor antagonist 62 NS5B polymerase 62 metastatic pancreatic 62 Pharmacokinetics PK 62 recurrent glioblastoma multiforme 62 ovarian pancreatic 62 Thiovir 62 immune modulatory 62 ketolide antibiotic 62 VEGF inhibitors 62 nilotinib Tasigna 62 alkylating 62 seliciclib CYC# 62 Denufosol 62 finasteride Proscar 62 LHRH antagonist 62 bevacizumab Avastin R 62 myeloproliferative disorders 62 Saxagliptin 62 MEK inhibitors 62 ATRA IV 62 somatostatin analog 62 pharmacologically active isomer 62 ALN HPN 62 afamelanotide 62 novel emulsion formulation 62 oral deforolimus 62 NS5b 62 targeting CD# 62 Inc. AMEX YMI 62 refractory acute myeloid 62 CCR5 antagonist 62 Pimavanserin 62 immunomodulating 62 HCV polymerase 62 HGS ETR1 mapatumumab 62 vapreotide acetate 62 unresectable tumors 62 Sapacitabine 62 Interferon alpha 62 Deforolimus 62 ovarian breast 62 receptor modulators 62 pediatric malignancies 62 mda 7 62 NS#/#A protease 62 Onalta TM 62 Rituxan rituximab 62 GRNVAC1 62 INSPIRE Trial Phase III 62 investigational pharmacologically unique 62 Zorbtive TM 62 autologous cellular immunotherapy 62 HCV RNA polymerase 62 vemurafenib 62 ELND-#/AZD-# 62 investigational monoclonal antibody 62 androgen independent 62 K ras mutations 62 hormone refractory metastatic prostate 62 Alfacell proprietary ribonuclease 62 CVac 62 demethylating agents 62 refractory indolent non 62 Raptiva R 62 Kevetrin ™ 62 metformin XR 62 selective agonist 62 developing Bicifadine serotonin 62 virus HCV protease inhibitor 62 fluoroquinolone antibiotic 62 Alkeran 62 PrevOnco 62 Clofarabine 62 Bazedoxifene 62 Waldenstrom macroglobulinemia 62 orally bioavailable 62 nucleotide analogue 62 pancreatic neuroendocrine tumors 62 targets Galectin receptors 62 Epidermal Growth Factor Receptor 62 hyperphenylalaninemia HPA due 62 signal transduction inhibitor 62 Aurora Kinase 62 Tesetaxel 62 lexidronam injection 62 Myocet 62 enzyme inhibitor 62 anti idiotype 62 cyclophilin inhibitors 62 EGFR HER2 62 ara C 62 nucleoside reverse transcriptase inhibitor 62 Virulizin ® 62 Annamycin 62 histone deacetylase HDAC inhibitors 62 AFREZZA TM 62 HSP# inhibitor 62 Amplimexon 62 vincristine doxorubicin 62 tarenflurbil 62 IMiDs ® compound 62 OMNARIS HFA 62 metastatic castration resistant 62 BiTE R 62 lintuzumab SGN 62 MVA BN 62 Tesmilifene 62 novel peptides 62 monoclonal anti 62 humanized therapeutic 62 Topoisomerase II 62 telomerase activators 62 Ostabolin C TM 62 Chronic lymphocytic leukemia 62 Chronic lymphocytic leukemia CLL 62 Combination REOLYSIN R 62 commercialize deforolimus 62 Thiarabine 62 itraconazole Sporanox 62 Personalized Immunotherapy 62 Pemetrexed 62 Neulasta R 62 humanised monoclonal antibody 62 Ixabepilone 62 oral antiviral 62 orally bioavailable mimics 62 bortezomib Velcade 62 Anticalins R 62 TRAIL R2 62 Cytoxan ® 62 Curaxin 62 ASG 5ME 62 XL# anticancer compounds 62 Viread tenofovir disoproxil fumarate 62 antiangiogenesis therapies 62 rasagiline tablets 62 #mg/#mg 62 OvaRex R 62 DCCR 62 Fulvestrant 62 Vicinium TM 62 HyperAcute 62 TLR9 agonist 62 KRAS mutant 62 molecular diagnostic assay 62 bendamustine HCl 62 lenalidomide dexamethasone 62 AAG geldanamycin analog 62 lymphomas leukemias 62 kinase inhibition 62 immunomodulatory therapy 62 AVAPRO 62 pancreatic prostate 62 personalized dendritic 62 HuCNS SC ® 62 Myelodysplastic Syndrome MDS 62 Anavex #-# 62 Pazopanib 62 Zolinza 62 selectively inhibited 62 depsipeptide 62 ARIKACE ™ 62 ovarian endometrial 62 paclitaxel poliglumex 62 OvaRex ® MAb 62 antiangiogenic agent 62 LEAPS TM 62 ulimorelin 62 JVRS 62 Cloretazine VNP#M 62 ovarian prostate 62 KRAS oncogene 62 bexarotene 62 psoriasis rheumatoid arthritis 62 toenail onychomycosis 62 interferon gamma 1b 62 Mg Uk 62 chronic thromboembolic pulmonary 62 novel immunotherapeutic 62 topical gel formulation 62 sapacitabine CYC# 62 CYP#A# CYP#D# 62 Caelyx 62 Enzastaurin 62 refractory metastatic 62 indolent follicular non 62 Mitoxantrone 62 recurrent epithelial ovarian 62 paclitaxel Taxol R 62 Vaprisol 62 CYC# 62 Liprotamase 62 peptide conjugated 62 Clevudine 61 CDK cyclin dependent 61 IAP inhibitors 61 orally inhaled migraine 61 antisense inhibitor 61 5 HT2A inverse 61 include ColorectAlert TM 61 Campath alemtuzumab 61 Smac mimetics 61 oral picoplatin 61 luteinizing hormone releasing 61 cetuximab Erbitux ® 61 Phase Ib II 61 Septin9 biomarker 61 Leukine ® 61 LRP5 61 Sustiva efavirenz 61 hormone LHRH antagonist 61 Cotara ® 61 farletuzumab 61 small molecule glucokinase 61 Gefitinib 61 cilengitide 61 immuno therapeutic 61 CCR9 antagonist 61 chronic myeloid 61 small molecule tyrosine 61 therapeutic peptide 61 Fingolimod 61 nonsmall cell lung cancer 61 oropharyngeal candidiasis OPC 61 dacarbazine DTIC 61 bevacizumab Avastin ® 61 interleukin IL -# 61 Ophena TM 61 geldanamycin 61 Intravenous Human 61 LHRH antagonists 61 anastrazole 61 peptibody 61 Atelvia 61 beta secretase inhibitors 61 mTOR inhibitor 61 myelofibrosis polycythemia vera 61 bortezomib Velcade R 61 Eraxis 61 histamine dihydrochloride 61 #I TM# 61 TTR amyloidosis 61 adefovir dipivoxil 61 DCVax R 61 topoisomerase II inhibitor 61 PDX pralatrexate 61 AEG# 61 vorinostat 61 targeting PCSK9 61 ImmunoGen TAP technology 61 lipid nanoparticle 61 fosbretabulin 61 HepDirect prodrug 61 humanized antibody 61 inverse agonist 61 nilotinib Tasigna ® 61 Interferon beta 61 OMP #R# 61 TKB# 61 PF # [002] 61 thrombin receptor 61 Trastuzumab DM1 61 ChronVac C R 61 Cancidas 61 romidepsin 61 Locked Nucleic Acid LNA 61 deCODE BreastCancer 61 Lilly Gemzar 61 SinuNase TM 61 lenalidomide Revlimid R 61 IV Busulfex 61 PANVAC VF 61 bucindolol hydrochloride 61 volociximab 61 tumor xenograft models 61 agonist LABA 61 polycythemia vera PV 61 HIV integrase inhibitor 61 PD LID 61 investigational humanized monoclonal antibody 61 ATL# [001] 61 sJIA 61 hypermethylated 61 Familial Adenomatous Polyposis FAP 61 docetaxel Taxotere 61 Zalypsis 61 Herceptin trastuzumab 61 Janus Kinase 61 HyACT 61 IMPDH inhibitor 61 Zytiga 61 relapsed ovarian cancer 61 apricitabine ATC 61 Ixempra 61 Novolimus 61 MEK inhibitor 61 acting inhaled anticholinergic 61 CG# [003] 61 CYP#A# substrate 61 Cloretazine ® 61 recurrent metastatic 61 Raptiva ® 61 Bayer HealthCare Onyx Pharmaceuticals 61 anti CD3 61 efalizumab 61 5 FU leucovorin 61 estrogen receptor antagonist 61 Janus kinase 61 alpha folate receptor 61 pegylated liposomal doxorubicin 61 irinotecan doxorubicin oxaliplatin paclitaxel 61 ALN TTR 61 alpha1 antitrypsin deficiency 61 prognostic biomarker 61 mesylate 61 synthetic retinoid 61 Irinotecan 61 galiximab 61 CTA# 61 trastuzumab DM1 T DM1 61 Gleevec imatinib mesylate 61 ergot derivatives 61 Aplidin R 61 pegylated alpha interferon 61 Oral Spray 61 Interferon Alpha 61 Moxifloxacin 61 CBLC# 61 NPM1 mutations 61 AMPK activators 61 Rasagiline 61 neovascular diseases 61 BRAF inhibitor 61 NSCLC tumors 61 ghrelin antagonist 61 phosphatidylserine PS targeting 61 Voreloxin 61 bortezomib Velcade ® 61 myelodysplastic myeloproliferative diseases 61 CLORETAZINE TM VNP#M 61 APOPTONE 61 oral proteasome inhibitor 61 triciribine phosphate monohydrate 61 DEB# 61 Ozarelix 61 liposomal doxorubicin 61 5 HT4 61 Arimidex anastrozole 61 ritonavir boosted 61 Protelos R 61 Upregulation 61 JAK2 Inhibitor 61 patientswith 61 mediated inhibition 61 trastuzumab DM1 61 Shows Promise Against 61 Bevacizumab Avastin 61 multicenter Phase III 61 polyglutamate 61 adenosine A2A 61 vinca alkaloids 61 advanced medullary thyroid 61 surgically resectable 61 Zybrestat 61 VALSTAR TM 61 TOCOSOL 61 myeloproliferative diseases 61 SCIB1 61 ALK inhibitor 61 R roscovitine 61 hormone refractory 61 ANTISENILIN R 61 acetonide FA 61 Arranon 61 TransVax TM 61 ProLindac TM 61 miconazole Lauriad ® 61 JAK1 61 poly ADP ribose polymerase 61 Amgen Neulasta ® 61 proteasome inhibitors 61 Medullary thyroid cancer 61 oxazolidinone 61 ALN PCS 61 small molecule activators 61 IMC #B 61 IAP inhibitor 61 talabostat 61 Granulocyte Colony Stimulating Factor 61 vascular disrupting agents 61 beta2 agonist 61 5alpha reductase 61 cytolytic 61 gamma secretase inhibitor 61 Cathepsin S 61 sunitinib Sutent ® 61 pathophysiological effects 61 Cloretazine 61 Solazed 61 Taxotere chemotherapy 61 GSTP1 61 Vascular Disrupting Agent 61 Hsp# inhibition 61 Ribavirin causes 61 Ganciclovir 61 Nexavar sorafenib 61 Insegia 61 Crofelemer budesonide foam 61 Oracea TM 61 NuroPro PD 61 PI3K inhibitor 61 chemopreventive agent 61 CCR5 inhibitor 61 systemic juvenile idiopathic 61 GMX# 61 Mammastatin 61 secondary hyperparathyroidism 61 candidate CRLX# 61 Glufosfamide 61 Transdrug ® nanoparticle 61 5 HT3 antagonist 61 HCV replicon 61 HCD# [002] 61 humanized anti 61 neuronal nicotinic receptor NNR 61 Tumor Necrosis Factor 61 Kinase Inhibitor 61 Hepsera adefovir dipivoxil 61 relapsed ALL 61 non nucleoside 61 Tarvacin 61 DNA methyltransferase inhibitors 61 Gemzar ® 61 BiTE ® 61 chemotherapy induced neutropenia 61 recombinant FVIII 60 Vandetanib 60 protein kinase inhibitor 60 BrachySil ™ 60 IL# PE#QQR 60 Begins Dosing 60 aleglitazar 60 Radiation Therapy SIRT 60 dexamethasone Decadron 60 Alferon LDO 60 PDE4 modulators 60 refractory prostate cancer 60 TÎ ² 4 60 Src inhibitors 60 novel peptide 60 DOS# 60 TRIOLEX HE# 60 dimebon latrepirdine 60 pain palliation 60 ceftazidime 60 FOLFOX6 60 PORxin TM 60 breast pancreatic 60 Hedgehog pathway inhibitor 60 ocular formulation 60 epothilone 60 PDGF receptor 60 small molecule agonists 60 immunomodulatory properties 60 chemotherapy cisplatin 60 mTOR inhibitors 60 Triapine R 60 oral dihydropyrimidine dehydrogenase DPD 60 Initiates Enrollment 60 pralatrexate injection folate analogue 60 molecular imaging radiopharmaceuticals 60 cell acute lymphoblastic 60 activate SIRT1 60 DP VPA 60 Elagolix 60 RELOVAIR ™ 60 Asentar 60 HGS# 60 drug zotarolimus 60 TLR7 agonist 60 SIR Spheres 60 romazarit 60 Micromet BiTE 60 TELINTRA 60 Sprycel dasatinib 60 zidovudine AZT 60 adecatumumab MT# 60 gemcitabine Gemzar 60 tumors GIST 60 pan histone deacetylase 60 theranostic 60 TransVax tm 60 allogeneic cell 60 CDDO Im 60 vaccines oncolytic virus 60 Liposomal 60 JAK inhibitor 60 nitric oxide donating prostaglandin 60 Acute myeloid leukemia AML 60 TELINTRA R 60 Tofacitinib 60 oral nucleoside analogue 60 colorectal lung 60 Kinoid 60 GVAX R 60 RNAi therapeutic targeting 60 Bendamustine 60 anthracycline taxane 60 HuMax HepC 60 Tezampanel 60 CDK inhibitor 60 Phase 1a clinical 60 Delafloxacin 60 Tyrima 60 lead molecular radiotherapeutic 60 tenofovir TDF 60 Angiocept 60 Dasatinib 60 acute myeloid 60 Preclinical studies suggest 60 selective phosphodiesterase 60 HER2 positive metastatic breast 60 follicular Non Hodgkin 60 metastatic neuroendocrine tumors 60 Dacogen decitabine 60 Oral NKTR 60 fallopian tube carcinoma 60 demethylating agent 60 investigational oral inhibitor 60 investigational protease inhibitor 60 prokinetic agent 60 hPTH #-# 60 SPL# Gel vaginal microbicide 60 Hexvix ® 60 RNA antagonist 60 Initiates Phase II 60 visilizumab 60 Prolastin A1PI 60 successfully commercialize Iluvien 60 cediranib 60 Modrenal 60 Neuvenge 60 Mipomersen 60 Maribavir 60 investigational pan BCR 60 Plavix clopidogrel bisulfate 60 STELARA ™ 60 potently inhibits 60 multiple myeloma MM 60 selective S#P# receptor agonist 60 Lymphocytic 60 selective antagonist 60 polymerase inhibitor 60 Neulasta ® 60 BMS # 60 Severe Sepsis 60 immune stimulatory 60 CDP# 60 A3 adenosine receptor 60 Triapine 60 TRO# 60 ALS #-# 60 Doxil ® 60 cetuximab Erbitux 60 molecular imaging radiopharmaceutical 60 KNS # 60 Lixivaptan 60 SNT MC# 60 Bosutinib 60 RH1 60 Abacavir 60 polycythemia vera essential thrombocythemia 60 TRIOLEX HE# APOPTONE HE# 60 LEUKINE 60 Small Modular SMIP 60 HuMax TAC 60 Zarnestra 60 Aptamer 60 Davanat 60 Traficet EN 60 mitotic kinesins 60 leukotriene B4 60 transthyretin amyloidosis 60 retinoic acid receptor 60 trial evaluating PRX# 60 Enzyme Replacement Therapy 60 tiapamil 60 radezolid 60 TPI ASM8 60 Initiate Clinical Trial 60 AVONEX ® 60 Factor VIIa 60 PCA3 gene 60 therapeutic monoclonal antibodies 60 T1c 60 Navelbine ® 60 treat chronic sinusitis 60 colorectal bladder 60 mapatumumab 60 Genasense ® 60 differentiated thyroid 60 concurrent chemoradiation 60 hypoxia inducible factor 60 MKC# MKC# PP 60 EndoTAGTM 1 60 Collategene 60 Oasmia 60 Maxy G# 60 oral Azacitidine 60 HCV protease inhibitor 60 trastuzumab Herceptin R 60 renin inhibitors 60 mTOR kinase 60 orally inhaled 60 Squamous 60 GeneICE 60 eIF 4E 60 predictive biomarkers 60 octreotide acetate 60 mGluR4 60 NXL# 60 XL# XL# XL# XL# 60 Pegasys peginterferon alfa 2a 60 non splenectomized 60 GAMMAGARD 60 novel anticancer